Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Happy Holiday! Limited Keychain here with your next orderHappy Holiday! Limited Keychain here with your next order
Time Limited Offer: Welcome Gift for New Customers ! Shipping Price Reduction for EU Regions
Project Name | Modality | Therapeutic Area | Indications | Stage | Right Available |
CD37+CD22 CAR-T | Cell therapy | Oncology/Cancer | AML | PCC | Global |
Kat. Nr. | Arten | Produktbeschreibung | Struktur | Reinheit | Merkmal |
---|---|---|---|---|---|
CD7-H52P4 | Human | Human CD37 Full Length Protein (VLP) | |||
CD7-H52H3 | Human | Human CD37 Protein, His Tag |
|
||
CD7-HF26x | Human | FITC-Labeled Human CD37 Protein, Fc Tag |
|
||
CD7-H525a | Human | Human CD37 Protein, Fc Tag (MALS verified) |
|
||
CD7-H526x | Human | Human CD37 Protein, Fc Tag |
|
Please contact us via TechSupport@acrobiosystems.com if you have any question on this product.
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Lutetium (177lu) lilotomab satetraxetan | 177Lu-DOTA-HH1 | Phase 2 Clinical | Nordic Nanovector | Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Follicular; Lymphoma, Non-Hodgkin | Details |
Naratuximab emtansine | IMGN-529; K7153A-SMCC-DM1 | Phase 2 Clinical | Immunogen Inc | Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Chronic, B-Cell | Details |
AGS-67E | AGS-67E | Phase 1 Clinical | Agensys Inc | Leukemia, Hairy Cell; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Chronic, B-Cell | Details |
BI-836826 | mAb-37.1; mAb-37.2; BI-836826 | Phase 1 Clinical | C.H. Boehringer Sohn Ag & Co. Kg | Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Chronic, B-Cell | Details |
CAR-37 T cell therapy (Massachusetts General Hospital) | Phase 1 Clinical | Massachusetts General Hospital | Lymphoma, B-Cell; Leukemia; Hematologic Neoplasms; Lymphoma; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell | Details | |
QLP-31907 | QLP-31907; QLP31907; PSB-202 | Phase 1 Clinical | Qilu Pharmaceutical Co Ltd | Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Waldenstrom Macroglobulinemia; Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Chronic, B-Cell | Details |
Lutetium (177lu) lilotomab satetraxetan | 177Lu-DOTA-HH1 | Phase 2 Clinical | Nordic Nanovector | Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Follicular; Lymphoma, Non-Hodgkin | Details |
Naratuximab emtansine | IMGN-529; K7153A-SMCC-DM1 | Phase 2 Clinical | Immunogen Inc | Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Chronic, B-Cell | Details |
AGS-67E | AGS-67E | Phase 1 Clinical | Agensys Inc | Leukemia, Hairy Cell; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Chronic, B-Cell | Details |
BI-836826 | mAb-37.1; mAb-37.2; BI-836826 | Phase 1 Clinical | C.H. Boehringer Sohn Ag & Co. Kg | Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Chronic, B-Cell | Details |
CAR-37 T cell therapy (Massachusetts General Hospital) | Phase 1 Clinical | Massachusetts General Hospital | Lymphoma, B-Cell; Leukemia; Hematologic Neoplasms; Lymphoma; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell | Details | |
QLP-31907 | QLP-31907; QLP31907; PSB-202 | Phase 1 Clinical | Qilu Pharmaceutical Co Ltd | Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Waldenstrom Macroglobulinemia; Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, Chronic, B-Cell | Details |
This web search service is supported by Google Inc.